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Abstract
Background: In many resource poor settings only sputum microscopy is employed for the
diagnosis of HIV-associated pulmonary tuberculosis; sputum culture may not be available.
Methods: We determined the diagnostic accuracy of sputum microscopy for active case finding of
HIV-associated pulmonary tuberculosis using TB culture as the reference standard.
Results: 2216 potential subjects screened for a TB vaccine trial submitted 9454 expectorated
sputum specimens: 212 (2.2%) were sputum culture positive for Mycobacterium tuberculosis (MTB),
31 (0.3%) for non-tuberculous mycobacteria, and 79 (0.8%) were contaminated. The overall
sensitivity of sputum microscopy was 61.8% (131/212) and specificity 99.7% (9108/9132). Sputum
microscopy sensitivity varied from 22.6% in specimens with < 20 colony forming units (CFU)/
specimen to 94.2% in patients with > 100 CFU/specimen plus confluent growth. The incremental
diagnostic value for sputum microscopy was 92.1%, 1.8% and 7.1% for the first, second and third
specimens, respectively. The positive predictive value and negative predictive values for sputum
microscopy were 84.5% and 99.1%, respectively. The likelihood ratio (LR) of a positive sputum
microscopy was 235.1 (95% CI 155.8 – 354.8), while the LR of a negative test was 0.38 (95CI 0.32
– 0.45). The 212 positive sputum cultures for MTB represented 103 patients; sputum microscopy
was positive for 57 (55.3%) of 103 patients.
Conclusion: Sputum microscopy on 3 expectorated sputum specimens will only detect 55% of
culture positive HIV-infected patients in active screening for pulmonary tuberculosis. Sensitivity is
higher in patients with greater numbers of CFUs in the sputum. Culture is required for active case
finding of HIV- associated pulmonary tuberculosis.
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Background
Despite recent advances in mycobacteriology [1], early
laboratory diagnosis of tuberculosis in the vast majority of
disease-endemic countries remains microscopic examination of the stained sputum smear [2,3]. The standard
WHO recommendation for TB diagnosis in the DOTS program is the use of direct sputum microscopy on 3 stained
sputum specimens [4]. First and third are on spot, while
the second is the early morning sample. Currently no
other diagnostic tool, including sputum culture, is available which could be implemented affordably in resource
poor settings, where the burden of disease is greatest.
However, even before the current HIV epidemic it was recognized that the sensitivity of sputum microscopy for the
microbiologic confirmation of TB was limited. With HIV
infection the sensitivity of sputum microscopy may be
reduced even further because of the lower rate of caseation
necrosis, and consequent lower numbers of AFB in the airway [5]. HIV may also reduce the specificity of sputum
microscopy by increasing the proportion of patients with
non-tuberculous mycobacteria [6]. Further, there is still a
debate about whether two or three sputum specimens
should be examined for diagnosis of TB [7-9]. Reducing
the recommended number of specimens examined from
three to two could benefit TB control programs by using
fewer resources and by reducing the time spent on case
detection [10]. In the present study we assessed the test
characteristics of smear microscopy on three concentrated
sputum specimens during active TB case finding among
HIV-infected patients in Dar es Salaam, Tanzania.

Methods
Patients and study protocol
Participants were 2216 HIV-positive subjects screened for
enrollment in the DARDAR Study between October 2001
and September 2006. DARDAR is a study on the epidemiology and vaccine-based prevention of HIV-associated
tuberculosis [11] being conducted in Dar es Salaam, Tanzania. Eligibility required a CD4 count > 200, a BCG scar,
and no evidence of active TB. At baseline, all potential
subjects had a physical examination and standardized
interview that included questions about weight loss in the
past 3 months and about the presence and duration of any
cough or fever. All subjects had a baseline chest x-ray and
submitted 3 expectorated sputum samples for microbiologic testing. Subjects were instructed in the need for deep
cough and asked to provide one spot sputum sample and
to label and bring two first morning samples; subjects
who were unable to produce a spot specimen were asked
to bring three first morning samples. Subjects with active
TB on baseline screening were not eligible for further
study. Eligible subjects were started on the immunization
protocol and were seen every 3 months and whenever
new symptoms develop. At each visit subjects were re-
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evaluated for tuberculosis with physical examination,
chest x-ray and collection of 3 expectorated sputum samples.
Laboratory methods
Sputum samples were decontaminated using the modified Petroff's method and concentrated by centrifugation
at 3000 g for 15 minutes. Smears were screened by
auramine staining and positive smears were counterstained by the Ziehl Neelsen (ZN) staining technique
without removing the auramine. Smears were read without knowledge of culture outcomes and results were categorized as 3+ (> 10 AFB/oil field), 2+ (1 – 10 AFB/oil
field), 1+ (10 – 99 AFB/100 oil fields), scanty (1 – 9 AFB/
100 oil fields) and negative (0 AFB/100 oil fields). For
each smear, a total of 100 microscopic fields were examined as per protocol. Each sample was then cultured in
both pyruvate and glycerol containing Lowenstein Jensen
media at 37°C for up to 8 weeks. Plates were examined
weekly for growth. Colonies were identified according to
criteria based on the speed of growth and macroscopic
features e.g. roughness and pigment production. Culture
results were expressed as actual number of colonies (if less
than 20 colonies/slant) 1+ (20–100 colonies/slant, 2+
(discrete innumerable colonies/slant) and 3+ (for confluent growth). Positive cultures were shipped to the US for
confirmation by DNA probe (AccuProbe, San Diego, CA,
USA).
Quality assurance
Quality assurance was accomplished by assessing the
quality and adequacy of specimens, and by monitoring
microscopy and culture procedures, preparation and storage of reagents and performance of equipment against
established laboratory operating procedures. Patients
were requested to provide an additional specimen in case
of submitting either an inadequate or salivary sample.

For smear microscopy, positive and negative control slides
were included with each batch of new reagents and, in a
blind manner, when reading patient smears. All slides
were read independently by three experienced microscopists, and kept for up to three months for external
quality control. Review of smear and culture results provided an internal quality assurance measure. Additional
quality measures for cultures included monitoring of;
quality of water, decontamination, digestion, and concentration procedures, inspissation and incubation temperatures, and measurement and adjustment of pH of culture
media. A standard laboratory strain M. tuberculosis H37Rv
was used as a positive control. Identification of mycobacteria was based on growth and colonial morphology and
was confirmed by further testing of the isolates using DNA
probes (Accuprobe; Gen-Probe).
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Between 2001 and 2006 the study laboratory participated
in the UK National External Quality Assurance Scheme for
TB sputum microscopy and sputum culture, and had
cumulative scores of 100% and 98% for SM and sputum
culture, respectively.

Table 1: Sputum microscopy and sputum culture results on all
specimens

Ethics
The research protocol was approved by the Ethics Committee of the Muhimbili University of Health and Allied
Sciences and the Dartmouth Committee for the Protection of Human Subjects.

SC negative

Total

SM positive
SM negative

1311
81

24
9108

155
9189

Total

2122

9132

93443,4

1 103

patients
probes performed on 166 isolates (94 SM positive, 72 SM
negative); 46 additional isolates considered MTB based on growth and
culture morphology
3 Excludes 79 culture contaminated and 31 NTM
4 Test characteristics of SM:
Sensitivity = 131/212 = 61.8%(95% CI 54.9% -68.4%)
Specificity = 9108/9132 = 99.7% (95% CI 99.6% – 99.8%)
Positive predictive value = 131/155 = 84.5% (95% CI 77.8% –
89.8%),
Negative predictive value = 9108/9189 = 99.1% (95% CI 98.9% –
99.3%)
LR (positive smear microscopy) = 235.1 (95% CI 155.8 – 354.3)
LR (negative smear microscopy) = 0.38 (95% CI 0.32 – 0.45)
2 DNA

Statistical analysis
The sensitivity, specificity, positive and negative predictive
values of the sputum smear examinations were calculated
by using the sputum culture results as the "gold standard."

Results
Between October 2001 and September 2006 a total of
2216 potential study subjects submitted 9454 expectorated sputum specimens for examination. Of the 9454
specimens, 212 (2.2%) were sputum culture positive for
MTB, 31 (0.3%) were sputum culture positive for NTM,
and 79 (0.8%) were contaminated (Table 1). DNA probes
were available on 166 of 212 specimens and were uniformly positive (the remaining samples were either contaminated or not viable when received in the US for
testing). Sensitivity and specificity of direct sputum microscopy were 61.8% and 99.7%, respectively based on total
samples submitted. Sputum microscopy positivity varied
from 22.6% in patients whose culture yielded < 20 CFU
per slant to 94.2% in patients with > 100 CFU and confluent growth (Table 2). The positive predictive value (PPV)
and negative predictive value (NPV) for direct SM were
84.5% and 99.1%, respectively based on total samples
submitted. The likelihood ratio (LR) of a positive sputum
microscopy was 235.1 (95% CI 155.8 – 354.8), while the
LR of a negative test was 0.38 (95CI 0.32 – 0.45).

SC positive

A total of 103 (4.6%) subjects were sputum culture positive for MTB, 27 (1.2%) were sputum culture positive for
NTM and 2 (0.1%) sputum culture positive for both MTB
and NTM. Of the 103 subjects sputum culture positive for
MTB, 40 (70%) had one positive sputum culture, 30
(29%) had two positive sputum cultures, and 33 (32%)
had three positive sputum cultures. The incremental diagnostic yield was 74.8%, 9.7% and 15.5% for the first, second and third sputum culture respectively.
Sputum microscopy was positive for 57 (55%) of the 103
sputum culture positive subjects. Of the 57 smear positive
patients, 12 (21%) had one positive smear, 14 (25%) had
two positive smears and 31 (54%) had three positive
smears. Forty seven patients has culture positive and
smear negative results, of whom 31 (~66.0%) had one
positive culture, 12 (25.5%) had two positive cultures and
4 (8.5%) had three positive cultures (Table 3). Most of the
patients (22/31) who had one positive culture had growth

Table 2: Relation of colony forming units (CFUs) on culture to sensitivity of smear microscopy in 212 sputum samples

Quantitative sputum smear results
Quantitative sputum culture
results

< 10 afb/100
field

1+ (10–99afb/100
field)

2+ (1–10 afb/
field)

3+ (> 10 afb/
field)

Neg Total SM pos %

< 20 CFU
1+ (20–100 CFU)
2+ (> 100 CFU with discrete
innumerable colonies)
3+ (> 100 CFU with confluent
innumerable colonies)

4
8
5

6
15
11

1
4
4

1
4
3

41
31
5

53
62
28

22.6
50
82.1

7

17

15

26

4

69

94.2

Total

24

49

24

34

81

212

61.8
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Table 3: Sputum culture results in patients with negative sputum
smears

No. pos sputum
cultures

Quantitative sputum culture result

< 20 CFU

20–100 CFU

> 100 CFU

Total

1
2
3

22
6
1

6
3
3

2
3
0

30*
12
4

Total number

29

12

6

46

* 31 patients had one culture positive slant; however growth on one
slant could not be estimated

of < 20 colonies, while most of those who had growth on
all the three slants had a growth of 1+. Among seven sputum microscopy positive/sputum culture negative subjects, five were on TB treatment at the time sputum
samples were submitted (Table 4). The incremental diagnostic value was 92.1%, 1.8% and 7.1% for the first, second and third smears, respectively.

Discussion
The data presented here on active TB screening of HIVinfected subjects with CD4 counts > 200 and suspect TB
confirm that sputum microscopy is an insensitive tool for
TB diagnosis in this setting. In addition the data show that
the sensitivity of sputum microscopy is related to the bacterial burden in the positive sputum culture. The high levels of specificity, and positive predictive value of sputum
microscopy in this study indicates that a positive test is
useful in predicting the presence of pulmonary tuberculosis in HIV-infected individuals. The positive likelihood
ratio of the sputum microscopy (235) suggests that a positive test almost rules in the diagnosis. However the nega-

tive LR is indicates that the probability of TB is only
reduced by half in the face of a negative smear.
The level of sensitivity in the present study (61.8%) is
higher than that found in Kenya (33%) [12], another HIV
endemic area, which could be do to the fact that sputum
samples in our study were concentrated before examination and possible differences in the degree of immunosuppression between the studied populations. Eligibility
for the study required a CD4 count > 200, a BCG scar, and
no evidence of active TB. Thus the population tested may
have had different characteristics to those of a general
population of HIV positive individuals.
Despite the relatively higher sensitivity seen in our study,
almost three quarters of patients with < 20 CFU would be
missed by sputum microscopy. The consequences for this
are several, including i) delayed or misdiagnosed, contributing to delayed treatment and increased morbidity and
mortality rates [13-15]. For example, in the SIMHEALTH
611 study, 60% of the patients in whom the diagnosis of
TB was missed, were being treated for non-specific pneumonia prior to death [16], ii) continued spread of TB to
up to 20% of contacts [17], iii) underestimation of rates
of disease and iv) inadequate exclusion of active TB in
patients being considered for isoniazid preventive therapy
[18]. These facts coupled with the reality that smear-negative TB cases have a poor prognosis [19] highlight the
need for urgent measures to increase detection of smear
negative TB cases and to raise the sensitivity of SM. Several
laboratory methods have been tried such as sedimentation with either AFB phenol ammonium sulfate [20] or
sodium hypochlorite [21], use of chitin in mucus digestion [22] and concentration by centrifugation [23],but
most of these have limited testing under field conditions.

Table 4: Clinical, radiological and microbiological findings of 7 patients who had smear positive, culture negative results

Case Smear 1

Smear 2

Smear 3

1

1+ (10 – 99 AFB/100 oil fields) 1+ (10 – 99 AFB/100 oil fields) 3 AFBs

2

1+ (10 – 99 AFB/100 oil fields) Negative

3

1+ (10 – 99 AFB/100 oil fields) 1+ (10 – 99 AFB/100 oil fields) Negative

4
5

3AFBs/100 oil fields
6 AFBs/100 oil fileds

Negative
2 AFBs/100 oil fields

Negative
Negative

6

8 AFBs/100 oil fields

Negative

Negative

7

(> 10 AFB/oil field)

Negative

Negative

Negative

Clinical features
Cavity on CXR; patient treated for TB and
responded
Patient clinically well. Produced a total of 6
sputum specimens with only one positive
smear
Abdominal TB samples taken after TB Rx for
2 months.
Patient clinically well.
Fever and peritonitis with ascites by
ultrasound, CXR normal, samples taken after
2 months of treatment.
Prolonged cough and fever, CXR consistent
with TB. Treated for TB and improved
remarkably.
Culture positive pulmonary TB, repeat
samples taken after 2 months of treatment

Conclusion
TB
Not TB

TB
Not TB
TB

TB

TB
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Most of the patients who had culture positive and smear
negative result had discordant culture results. Majority of
these patients had only one positive slant that yielded less
than 20 colonies per slant, with only a few with three positive slants, which in many cases had a growth of 1+. However, there was no clear pattern of growth for those that
yielded two positive slants.
We observed seven cases that had smear positive and culture negative results. Five of these cases were on anti-TB
therapy, and it is likely that bacilli seen on the smears were
not viable. The other two patients had each only one
smear positive result, one had 3 AFB and the other had 1+,
and is likely to be due to laboratory contamination. This
is due to the fact that they had no signs or symptoms of
tuberculosis and subsequently had good clinical outcome
without TB therapy. Although the exact causes of these
contamination in our laboratory was not identified, it
may have resulted from either specimen mix-up, contamination of specimens or reagents with environmental
mycobacteria in water, use of single-reagent delivery systems for multiple specimens or contamination in the cabinet area arising from sharing of the facility with several
other laboratory workers of different projects. The significant diagnostic yield of the third smear found in this study
differs from most other reports and may be a reflection of
the particular method of sputum collection used in our
protocol. The relatively high diagnostic value of the third
smear is surprising because a recent systematic review of
37 studies show the third specimen lead to increase in
sensitivity by 3.1% (95% CI, 2.1 to 4.2%) [24]. The second specimen gave surprisingly low incremental yield for
both smears and cultures. This scenario may reflect poor
instructions for specimens collected at home or very good
instructions for the spot specimens and might also be due
to mislabeling of the sequence by patients or by improved
cough technique by the time of the third specimen. In our
study, two samples for sputum microscopy and one for
sputum culture would only detect TB in 76 (73.8%) of the
103 cases. However the problem of requesting three specimens would be that some patients may drop out of the
diagnostic pathway between submitting specimens and
being offered treatment [25]. This problem could be minimized by requesting two smears on the first visit [26] and
by providing patient education coupled with collaboration between treatment supporters, health workers and
community members in supervising TB patients [27].
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